ACOTEC SCIEN.H. DL-00001 Asset Resilience Ratio
ACOTEC SCIEN.H. DL-00001 asset resilience ratio. ACOTEC SCIEN.H. DL-00001 (7W3) has an Asset Resilience Ratio of 29.34% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can ACOTEC SCIEN.H. DL-00001 fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of ACOTEC SCIEN.H. DL-00001 (2023–2025)
Asset resilience ratio of ACOTEC SCIEN.H. DL-00001 from 2023 to 2025. This chart shows how ACOTEC SCIEN.H. DL-00001's Asset Resilience Ratio has changed over time. Read ACOTEC SCIEN.H. DL-00001 balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down ACOTEC SCIEN.H. DL-00001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ACOTEC SCIEN.H. DL-00001 (7W3) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €548.14 Million | 29.34% |
| Total Liquid Assets | €548.14 Million | 29.34% |
Asset Resilience Insights
- Very High Liquidity: ACOTEC SCIEN.H. DL-00001 maintains exceptional liquid asset reserves at 29.34% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
ACOTEC SCIEN.H. DL-00001 Industry Peers by Asset Resilience Ratio
Compare ACOTEC SCIEN.H. DL-00001's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
ACOTEC SCIEN.H. DL-00001 Asset Resilience Ratio by Year (2023–2025)
ACOTEC SCIEN.H. DL-00001 asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for ACOTEC SCIEN.H. DL-00001.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 29.34% | €548.14 Million ≈ $640.84 Million |
€1.87 Billion ≈ $2.18 Billion |
+22.56pp |
| 2024-12-31 | 6.78% | €112.80 Million ≈ $131.88 Million |
€1.66 Billion ≈ $1.94 Billion |
-8.21pp |
| 2023-12-31 | 15.00% | €241.58 Million ≈ $282.43 Million |
€1.61 Billion ≈ $1.88 Billion |
-- |
About ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more